Skip to main content
. 2024 Jun 18;23:206. doi: 10.1186/s12933-024-02260-9

Table 2.

Multivariate analysis of continuous ACR and stroke outcome (Rankin score 0–2 vs. 3–6)

OR (95% CI) p value
Male sex 0.84 (0.69–1.02) 0.084
Age 1.04 (1.03–1.05) < 0.001
Diabetes 1.55 (1.27–1.90) < 0.001
Previous mRS
mRS-0 REF REF
mRS-1 1.42 (1.08–1.86) 0.011
mRS-2 3.38 (2.57–4.45) < 0.001
Baseline NIHSS 1.19 (1.16–1.21) < 0.001
Treatment
No treatment REF REF
Endovascular treatment 0.68 (0.42–1.09) 0.109
Endovascular + rTPA 0.50 (0.38–0.65) < 0.001
ACR 1.07 (1.04–1.11) < 0.001

Values represent Odds Ratios (OR), 95% confidence intervals and p-values

ACR: acute-to-chronic glycaemic ratio; NIHSS: National Institutes of Health Stroke Scale; rtPA: recombinant tissue plasminogen activator